Yi et al. reported that in HCC patients, LZTR1-mediated H-RAS ubiquitination was inhibited by lncRNA, leading to the activation of MAPK signaling pathway and the induction of p-DRP1, which indicates a poor prognosis of HCC [37]. Here, HRAS is linked to hepatocellular carcinoma.